ResMed (RMD) Earnings Date, Estimates & Call Transcripts → Move Your Money Before May 22 (From Stansberry Research) (Ad) Free rmd Stock Alerts $218.06 +34.64 (+18.89%) (As of 04/26/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryUpcoming Earnings DateAug. 1EstimatedActual EPS (Apr. 25) $2.13 Beat By $0.22 Consensus EPS (Apr. 25) $1.91 Read Call TranscriptListen to Call Get ResMed Earnings AlertsEnter your email address below to receive the latest news and earnings results for RMD and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueRMD Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.RMD Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Stansberry ResearchMove Your Money Before May 22The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals. Here's where Dr. David Eifrig says to move your money immediately. ResMed Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20243$1.59$1.66$1.63Q2 20243$1.74$1.79$1.77Q3 20243$1.87$1.92$1.89Q4 20243$1.90$2.00$1.94FY 202412$7.10$7.37$7.23Q1 20252$1.93$1.94$1.94Q2 20252$2.06$2.06$2.06Q3 20252$2.02$2.10$2.06Q4 20252$2.02$2.20$2.11FY 20258$8.03$8.30$8.17Q1 20261$2.11$2.11$2.11Q2 20261$2.14$2.14$2.14Q3 20261$2.21$2.21$2.21RMD Earnings Date and InformationResMed last released its earnings data on April 25th, 2024. The medical equipment provider reported $2.13 EPS for the quarter, beating analysts' consensus estimates of $1.91 by $0.22. The firm earned $1.20 billion during the quarter, compared to the consensus estimate of $1.17 billion. Its revenue for the quarter was up 7.2% compared to the same quarter last year. ResMed has generated $6.05 earnings per share over the last year ($6.05 diluted earnings per share) and currently has a price-to-earnings ratio of 35.9. Earnings for ResMed are expected to grow by 10.84% in the coming year, from $7.47 to $8.28 per share. ResMed has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 1st, 2024 based off prior year's report dates.Read More ResMed Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/1/2024Estimated)------- 4/25/2024Q3 2024$1.91$2.13+$0.22$2.22$1.17 billion$1.20 billion 1/24/2024Q2 2024$1.81$1.88+$0.07$2.34$1.15 billion$1.16 billion 10/26/2023Q1 2024$1.63$1.64+$0.01$1.79$1.10 billion$1.10 billion 8/3/2023Q4 2023$1.67$1.60($0.07)$1.64$1.14 billion$1.12 billion 4/27/2023Q3 2023$1.58$1.68+$0.10$1.78$1.05 billion$1.12 billion 1/26/2023Q2 2023$1.62$1.66+$0.04$1.79$996.22 million$1.03 billion Get the Latest News and Ratings for RMD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ResMed and its competitors with MarketBeat's FREE daily newsletter. 10/27/2022Q1 2023$1.51$1.51-$1.59$946.07 million$950.30 million 8/11/2022Q4 2022$1.48$1.49+$0.01$1.65$912.53 million$914.74 million 4/28/2022Q3 2022$1.44$1.32($0.12)$1.42$900.03 million$864.50 million 1/27/2022Q2 2022$1.47$1.47-$1.57$927.49 million$894.60 million 10/28/2021Q3 2021$1.35$1.51+$0.16$1.63$858.20 million$904.00 million 8/5/2021Q2 2021$1.25$1.35+$0.10$1.37$781.10 million$876.10 million 4/29/2021Q3$1.22$1.30+$0.08$3.14$784.47 million$768.77 million ResMed Earnings - Frequently Asked Questions When is ResMed's earnings date? ResMed has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 1st, 2024 based off last year's report dates. Learn more on RMD's earnings history. Did ResMed beat their earnings estimates last quarter? In the previous quarter, ResMed (NYSE:RMD) reported $2.13 earnings per share (EPS) to beat the analysts' consensus estimate of $1.91 by $0.22. Learn more on analysts' earnings estimate vs. RMD's actual earnings. How can I listen to ResMed's earnings conference call? The conference call for ResMed's latest earnings report can be listened to online. Listen to Conference Call How can I read ResMed's conference call transcript? The conference call transcript for ResMed's latest earnings report can be read online. Read Transcript How much revenue does ResMed generate each year? ResMed (NYSE:RMD) has a recorded annual revenue of $4.22 billion. How much profit does ResMed generate each year? ResMed (NYSE:RMD) has a recorded net income of $897.56 million. RMD has generated $6.05 earnings per share over the last four quarters. What is ResMed's price-to-earnings ratio? ResMed (NYSE:RMD) has a trailing price-to-earnings ratio of 35.95 and a forward price-to-earnings ratio of 29.12. The price/earnings-to-growth ratio is 2.25. What is ResMed's EPS forecast for next year? ResMed's earnings are expected to grow from $7.47 per share to $8.28 per share in the next year, which is a 10.84% increase. More Earnings Resources from MarketBeat Related Companies: Baxter International Earnings Insulet Earnings Teleflex Earnings Globus Medical Earnings DexCom Earnings Becton, Dickinson and Company Earnings Boston Scientific Earnings West Pharmaceutical Services Earnings Shockwave Medical Earnings Penumbra Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings?Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting SeasonLululemon Stock Implodes Post Earnings, Guidance Muted This page (NYSE:RMD) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersFed launches fourth dollar overhaulStansberry ResearchMan Who Predicted 2008: “This Will be Worse.”AltimetryJim Cramer’s “The Biggest Drug Ever”Behind the MarketsEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsThe AI stock to buy right nowStockEarnings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ResMed Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
